Exome Asset Management LLC logo

Exome Asset Management LLC Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Exome Asset Management LLC with $148.0M in long positions as of Q3 2025, 89% allocated to Healthcare, and 42% concentrated in top 10 positions.

Portfolio Value
$148.0M
Top 10 Concentration
42%
Top Sector
Healthcare (89%)
US Exposure
98%
Market Cap Focus
Mid Cap
Countries
4

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 88.70%HealthcareTechnology: 1.20%
Healthcare
88.70%
Technology
1.20%

Industry Breakdown

10 industries across all sectors

Biotechnology: 62.94%BiotechnologyMedical - Diagnostics & Research: 6.17%Medical - Devices: 5.29%Drug Manufacturers - General: 4.05%Medical - Care Facilities: 3.58%Medical - Healthcare Plans: 2.22%4 more: 5.68%
Biotechnology
Healthcare
62.94%
Medical - Diagnostics & Research
Healthcare
6.17%
Medical - Devices
Healthcare
5.29%
Drug Manufacturers - General
Healthcare
4.05%
Medical - Care Facilities
Healthcare
3.58%
Medical - Healthcare Plans
Healthcare
2.22%
Medical - Instruments & Supplies
Healthcare
1.92%
Medical - Healthcare Information Services
Healthcare
1.29%
Medical - Distribution
Healthcare
1.27%
Information Technology Services
Technology
1.20%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mega Cap (> $200B): 4.05%Large Cap ($10B - $200B): 17.42%Large Cap ($10B - $200B)Mid Cap ($2B - $10B): 43.22%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 22.99%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 3.05%Nano Cap (< $50M): 1.27%N/A (ETF or Unknown): 8.00%
Mega Cap (> $200B)
4.05%
Large Cap ($10B - $200B)
17.42%
Mid Cap ($2B - $10B)
43.22%
Small Cap ($300M - $2B)
22.99%
Micro Cap ($50M - $300M)
3.05%
Nano Cap (< $50M)
1.27%
N/A (ETF or Unknown)
8.00%

Portfolio Concentration

Top 10 Holdings %
41.51%
Top 20 Holdings %
65.38%
Top 50 Holdings %
99.77%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
97.9%
International
2.1%
Countries
4
Largest Int'l Market
Netherlands - 0.87%
United States of America
97.90% ($144.9M)
49 holdings
Netherlands
0.87% ($1.3M)
1 holdings
Switzerland
0.86% ($1.3M)
1 holdings
Costa Rica
0.36% ($537.0K)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
3.6 quarters
Avg. Top 20
3 quarters
Avg. All Positions
2.4 quarters
Median Holding Period
1.5 quarters
Persistence Rate
28.85%
Persistent Holdings Weight
36.27%
Persistent Positions
15
Longest Held
Eli Lilly & Co. logo
Eli Lilly & Co.LLY - 7 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
1.41%
Avg. Position Weight
1.92%
Largest Position
Ionis Pharmaceuticals, Inc. Common Stock logo
Ionis Pharmaceuticals, Inc. Common StockIONS - 5.79%
Largest Ownership Stake
Corbus Pharmaceuticals Holdings, Inc. logo
Corbus Pharmaceuticals Holdings, Inc.CRBP - 1.88%
Avg. Ownership Stake
0.16%
Ownership Stake >5%
0
Ownership Stake >1%
1

Historical (Since Q4 2023)

Avg. New Position
1.65%
Avg. Ownership Stake
0.27%
Largest Position
Sarepta Therapeutics,, Inc. Common Stock logo
Sarepta Therapeutics,, Inc. Common StockSRPT - 22.37% (Q2 2025)
Largest Ownership Stake
Karyopharm Therapeutics Inc. logo
Karyopharm Therapeutics Inc.KPTI - 23.76% (Q1 2025)

Portfolio Turnover

Current Quarter

Turnover Ratio
42.5%
Value Traded
$62.96M
Positions Added
14
Positions Exited
21

Historical (Since Q4 2023)

Avg. Turnover Ratio
46.3%
Avg. Positions Added
22
Avg. Positions Exited
20
Highest Turnover
52.7%
Q2 2024
Lowest Turnover
32.3%
Q2 2025

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.